Simonetta Viviani is a senior scientific advisor and has collaborations with academia, vaccine manufacturing companies, and other institutions operating in the field of vaccine reasearch & development, epidemiology and global health. She was previously (2010-2012) Associate VP & Head Dengue Vaccine Clinical Development Program at Sanofi Pasteur. From 2005 to 2010, she was director of Vaccine Development at the Meningitis Vaccine Project (MVP), with the goal of eliminating epidemic meningitis from sub-Saharan Africa. From 2002 to 2005, she was clinical research and medical affairs manager at Berna Biotech in Bern, Switzerland. From 1997 to 2002, she was associate director of the clinical research department at Chiron Vaccines in Siena, Italy. From 1995 to 1997, she was posted as epidemiologist in The Gambia attached to The Gambia Hepatitis Intervention Study, a project of the International Agency for Research on Cancer (WHO), Lyon, France. Her experience in vaccine development includes pediatric vaccines, Hib, pertussis, measles, influenza, HIV, dengue, meningitis, hepatitis B, leptospirosis, polio, SARS-Cov2 vaccines. Dr. Viviani received a Medicine and Surgery Degree from Siena University, Italy, as well as postgraduate degrees in Public Health and Laboratory. She holds a two-year postgraduate training in Field Epidemiology from the CDC, Atlanta, USA, and the Istituto Superiore di Sanità, Rome, Italy. ORCID:https://orcid.org/0000-0002-3652-5082